AbCellera Presents Data On T-Cell Engagers Against Four Tumor Targets At AACR 2024
Data show how AbCellera is expanding the reach of T-cell engagers with:CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release across multiple tumor
